TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir

NCT01288755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: TMC278
DRUG: Raltegravir

Sponsor

Tibotec Pharmaceuticals, Ireland

Collaborators

[object Object]